Astellas Pharma Inc. (ALPMY)
OTCMKTS
· Delayed Price · Currency is USD
10.07
+0.50 (5.22%)
Apr 25, 2025, 4:00 PM EDT
Astellas Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 50,747 | 24,969 | 132,361 | 156,886 | 145,324 | Upgrade
|
| Depreciation & Amortization | 199,132 | 157,840 | 105,738 | 79,684 | 72,652 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 78,931 | 84,499 | 74,850 | 100,348 | Upgrade
|
| Asset Writedown & Restructuring Costs | 187,564 | - | - | - | - | Upgrade
|
| Other Operating Activities | -76,562 | -37,563 | -68,811 | -43,293 | -27,144 | Upgrade
|
| Change in Accounts Receivable | -104,735 | -55,948 | -4,849 | -8,001 | 22,161 | Upgrade
|
| Change in Inventory | -50,225 | -60,036 | -7,086 | 24,058 | -2,318 | Upgrade
|
| Change in Accounts Payable | -11,409 | 29,466 | -12,274 | -10,101 | -51,569 | Upgrade
|
| Change in Other Net Operating Assets | - | 34,816 | 98,189 | -16,639 | 47,389 | Upgrade
|
| Operating Cash Flow | 194,512 | 172,475 | 327,767 | 257,444 | 306,843 | Upgrade
|
| Operating Cash Flow Growth | 12.78% | -47.38% | 27.32% | -16.10% | 38.22% | Upgrade
|
| Capital Expenditures | -37,003 | -38,056 | -36,441 | -30,739 | -31,384 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 441 | 6,831 | Upgrade
|
| Cash Acquisitions | - | -784,974 | - | -670 | -14,916 | Upgrade
|
| Sale (Purchase) of Intangibles | -19,168 | -33,438 | -51,888 | -21,428 | -46,057 | Upgrade
|
| Investment in Securities | 12,920 | - | 12,624 | - | - | Upgrade
|
| Other Investing Activities | -46,168 | 10,666 | -8,795 | -10,017 | 3,632 | Upgrade
|
| Investing Cash Flow | -89,419 | -845,802 | -84,500 | -62,413 | -81,894 | Upgrade
|
| Short-Term Debt Issued | - | 324,337 | - | - | - | Upgrade
|
| Long-Term Debt Issued | 200,000 | 472,275 | 50,000 | - | 80,000 | Upgrade
|
| Total Debt Issued | 200,000 | 796,612 | 50,000 | - | 80,000 | Upgrade
|
| Short-Term Debt Repaid | -236,449 | - | -15,000 | - | - | Upgrade
|
| Long-Term Debt Repaid | -65,152 | -25,379 | -50,000 | -60,000 | -206,000 | Upgrade
|
| Total Debt Repaid | -301,601 | -25,379 | -65,000 | -60,000 | -206,000 | Upgrade
|
| Net Debt Issued (Repaid) | -101,601 | 771,233 | -15,000 | -60,000 | -126,000 | Upgrade
|
| Repurchase of Common Stock | -6,960 | -10,735 | -60,556 | -50,717 | -9,163 | Upgrade
|
| Common Dividends Paid | -128,993 | - | - | - | - | Upgrade
|
| Dividends Paid | -128,993 | -116,653 | -100,355 | -85,236 | -76,157 | Upgrade
|
| Other Financing Activities | -23,813 | -29,785 | -19,712 | -20,345 | -18,159 | Upgrade
|
| Financing Cash Flow | -261,367 | 614,060 | -195,623 | -216,298 | -229,479 | Upgrade
|
| Foreign Exchange Rate Adjustments | 8,960 | 18,113 | 13,210 | 11,125 | 12,267 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -1 | 1 | - | -1 | - | Upgrade
|
| Net Cash Flow | -147,315 | -41,153 | 60,854 | -10,143 | 7,737 | Upgrade
|
| Free Cash Flow | 157,509 | 134,419 | 291,326 | 226,705 | 275,459 | Upgrade
|
| Free Cash Flow Growth | 17.18% | -53.86% | 28.50% | -17.70% | 52.41% | Upgrade
|
| Free Cash Flow Margin | 8.24% | 8.38% | 19.18% | 17.49% | 22.05% | Upgrade
|
| Free Cash Flow Per Share | 87.64 | 74.69 | 159.63 | 122.50 | 148.24 | Upgrade
|
| Cash Income Tax Paid | 85,478 | 38,112 | 69,479 | 42,093 | 17,870 | Upgrade
|
| Levered Free Cash Flow | 104,951 | 134,671 | 202,242 | 174,913 | 155,051 | Upgrade
|
| Unlevered Free Cash Flow | 116,000 | 139,311 | 204,253 | 176,360 | 156,375 | Upgrade
|
| Change in Net Working Capital | 172,304 | 24,914 | -42,061 | -12,502 | -4,331 | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.